Abstract
DNA-based nanorobots have been shown to sense and respond to molecular triggers, such as intracellular pH and cell surface receptors. A recent report describes DNA nanorobots as potential cancer therapeutic agents that can be programmed to trigger coagulation inside blood vessels at the tumor site, starving tumor cells to death.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 591-593 |
Seitenumfang | 3 |
Fachzeitschrift | Trends in Molecular Medicine |
Jahrgang | 24 |
Ausgabenummer | 7 |
DOIs | |
Publikationsstatus | Veröffentlicht - Juli 2018 |